Step therapy limitations may cause patients to experience delays in receiving effective treatment and encounter avoidable disease progression, prolonged pain and potentially negative long-term effects ...

Insurers limit the use of certain prescription drugs by requiring step therapy—that is, by allowing access only after alternatives have been tried and have failed. Using data from seventeen of the ...

The Centers for Medicare and Medicaid Services recently sent shudders through the specialty drug market by authorizing Medicare Advantage Plans to use step therapy protocols for Part B drugs. The ...